Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| IO Biotech Inc | IOBT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.47 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.47 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.8163 - 2.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.47 | USD |
IO Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 96.84M | 65.88M | - | 0 | -86.08M | -1.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
IO Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOBT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.63 | 1.63 | 1.44 | 1.50 | 103,226 | -0.16 | -9.82% |
| 1 Month | 1.68 | 1.8453 | 1.44 | 1.61 | 99,625 | -0.21 | -12.50% |
| 3 Months | 1.79 | 1.89 | 1.44 | 1.63 | 142,244 | -0.32 | -17.88% |
| 6 Months | 1.07 | 2.098 | 0.8163 | 1.55 | 119,085 | 0.40 | 37.38% |
| 1 Year | 1.88 | 2.64 | 0.8163 | 1.62 | 143,009 | -0.41 | -21.81% |
| 3 Years | 16.00 | 17.88 | 0.8163 | 3.49 | 99,431 | -14.53 | -90.81% |
| 5 Years | 16.00 | 17.88 | 0.8163 | 3.49 | 99,431 | -14.53 | -90.81% |
IO Biotech Description
| IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. |
